Population impact and effectiveness of monovalent rotavirus vaccination in urban Malawian children 3 years after vaccine introduction: ecological and case-control analyses

Population impact and effectiveness of monovalent rotavirus vaccination in urban Malawian children 3 years after vaccine introduction: ecological and case-control analyses

Background. Rotavirus vaccines have been introduced in many low-income African countries including Malawi in 2012. Despite early evidence of vaccine impact, determining persistence of protection beyond infancy, the utility of the vaccine against specific rotavirus genotypes, and effectiveness in vul...

Bibliografske podrobnosti
Main Authors:	Bar-Zeev, N, Jere, K, Bennett, A, Pollock, L, Tate, J, Nakagomi, O, Iturriza-Gomara, M, Costello, A, Mwansambo, C, Parashar, U, Heyderman, R, French, N, Cunliffe, N
Format:	Journal article
Jezik:	English
Izdano:	Oxford University Press 2016

Podobne knjige/članki

Emergence of double- and triple-gene reassortant G1P[8] rotaviruses possessing a DS-1-Like backbone after rotavirus vaccine introduction in Malawi
od: Jere, KC, et al.
Izdano: (2018)

Cost-effectiveness of monovalent rotavirus vaccination of infants in Malawi: a postintroduction analysis using individual patient–level costing data
od: Bar-Zeev, N, et al.
Izdano: (2016)

Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study
od: Bar-Zeev, N, et al.
Izdano: (2018)

Vaccine Effectiveness against DS-1–Like Rotavirus Strains in Infants with Acute Gastroenteritis, Malawi, 2013–2015
od: Khuzwayo C. Jere, et al.
Izdano: (2019-09-01)

Population impact and effectiveness of sequential 13-valent pneumococcal conjugate and monovalent rotavirus vaccine introduction on infant mortality: prospective birth cohort studies from Malawi
od: Anthony Costello, et al.
Izdano: (2020-09-01)

Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies
od: Daniel Hungerford, et al.
Izdano: (2017-08-01)

Predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural malawi: a population cohort study.
od: Heinsbroek, E, et al.
Izdano: (2016)

Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study
od: Naor Bar-Zeev, PhD, et al.
Izdano: (2018-09-01)

Estimating the incidence of rotavirus infection in children from India and Malawi from serial anti-rotavirus IgA titres.
od: Aisleen Bennett, et al.
Izdano: (2017-01-01)

Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico
od: Marcelino Esparza-Aguilar, et al.
Izdano: (2014-02-01)

Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in Malawi
od: Benjamin Morgan, et al.
Izdano: (2024-09-01)

Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial
od: Tamika Fellows, et al.
Izdano: (2023-08-01)

Effectiveness of Monovalent Rotavirus Vaccine in Mozambique, a Country with a High Burden of Chronic Malnutrition
od: Assucênio Chissaque, et al.
Izdano: (2022-03-01)

The Challenges and Opportunities of Next-Generation Rotavirus Vaccines: Summary of an Expert Meeting with Vaccine Developers
od: Jessie Chen, et al.
Izdano: (2022-11-01)

Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines
od: Prisca Benedicto-Matambo, et al.
Izdano: (2022-03-01)

The control of diarrhea, the case of a rotavirus vaccine
od: Umesh D Parashar, et al.
Izdano: (2019-12-01)

Reduction in Severity of All-Cause Gastroenteritis Requiring Hospitalisation in Children Vaccinated against Rotavirus in Malawi
od: Jonathan J. Mandolo, et al.
Izdano: (2021-12-01)

Serotype G12 Rotaviruses, Lilongwe, Malawi
od: Nigel A. Cunliffe, et al.
Izdano: (2009-01-01)

A decade of experience with rotavirus vaccination in the United States – vaccine uptake, effectiveness, and impact
od: Talia Pindyck, et al.
Izdano: (2018-07-01)

Effectiveness of rotavirus vaccines against hospitalisations in Japan
od: Yoshiyuki Fujii, et al.
Izdano: (2017-07-01)

Radiographically confirmed pneumonia in Malawian children and associated pneumococcal carriage after introduction of the 13-valent pneumococcal conjugate vaccine
od: Grace Mzumara, et al.
Izdano: (2024-10-01)

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
od: A.D. Steele, et al.
Izdano: (2019-06-01)

Increased bacterial taxonomic and functional diversity is associated with impaired rotavirus vaccine immunogenicity in infants from India and Malawi
od: Edward Cunningham-Oakes, et al.
Izdano: (2023-11-01)

Rotavirus P[4]G2 in a Vaccinated Population, Brazil
od: Ricardo Queiroz Gurgel, et al.
Izdano: (2008-05-01)

Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK
od: Daniel Hungerford, et al.
Izdano: (2018-01-01)

Indirect protection from rotavirus vaccines: a systematic review
od: Tyler Chavers, et al.
Izdano: (2024-12-01)

Vitamin A deficiency impairs adaptive B and T cell responses to a prototype monovalent attenuated human rotavirus vaccine and virulent human rotavirus challenge in a gnotobiotic piglet model.
od: Kuldeep S Chattha, et al.
Izdano: (2013-01-01)

High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
od: Swarthout, TD, et al.
Izdano: (2020)

Stability Study of Razi Trivalent and Monovalent Oral Poliomyelitis Vaccine
od: Soleimani, S., et al.
Izdano: (2012-06-01)

Rotaviruses and Rotavirus Vaccines
od: Celeste M. Donato, et al.
Izdano: (2021-07-01)

Global estimates of rotavirus vaccine efficacy and effectiveness: a rapid review and meta-regression analysisResearch in context
od: Ottavia Prunas, et al.
Izdano: (2025-03-01)

Impact of rotavirus vaccination in Malawi from 2012 to 2022 compared to model predictions
od: Virginia E. Pitzer, et al.
Izdano: (2024-11-01)

EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
od: A.N. Mironov, et al.
Izdano: (2010-07-01)

EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
od: A.N. Mironov, et al.
Izdano: (2010-01-01)

Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia
od: Eleanor Burnett, et al.
Izdano: (2018-05-01)

Determinants of high residual post-PCV13 pneumococcal vaccine-type carriage in Blantyre, Malawi: a modelling study
od: Lourenço, J, et al.
Izdano: (2019)

Global rotavirus vaccine introductions and coverage: 2006 – 2016
od: Alice J. Abou-Nader, et al.
Izdano: (2018-09-01)

Rotavirus Strain Distribution before and after Introducing Rotavirus Vaccine in India
od: Tintu Varghese, et al.
Izdano: (2021-04-01)

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA
od: Ewer (nee Russell), K, et al.
Izdano: (2016)

Anti-rotavirus antibody measurement in a rotavirus vaccine trial: Choice of vaccine antigen in immunoassays does matter
od: Xiaoqian Wang, et al.
Izdano: (2023-01-01)